Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN) shares traded up 2.3% during mid-day trading on Monday . The company traded as high as C$1.82 and last traded at C$1.78. 46,869 shares were traded during trading, a decline of 58% from the average session volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Stock Performance
The stock has a 50-day moving average of C$1.78.
Neovasc Company Profile
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
See Also
- Five stocks we like better than Neovasc
- Business Services Stocks Investing
- Survey: Top 175 Fittest Retirement Locations in America
- ETF Screener: Uses and Step-by-Step Guide
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is the Dow Jones Industrial Average (DJIA)?
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.